David R Mole

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 13

Top Venues

Life science alliance

Cancer research

EMBO reports

Scientific reports

University of Oxford

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Oxford Oct 01 2016

United Kingdom

NIHR Research Professor and Honorary Consultant Nephrologist :: Nuffield Department of Medicine

University of Oxford Oct 01 2014

United Kingdom

Associate Professor & Honorary Consultant Nephrologist :: Nuffield Department of Medicine

University of Oxford Jun 01 2010 - May 31 2015

United Kingdom

HEFCE Clinical Senior Lecturer & Honorary Consultant Nephrologist :: Nuffield Department of Medicine

University of Oxford Jun 01 2006 - May 31 2010

United Kingdom

Wellcome Trust Intermediate Clinical Fellow & Honorary Consultant Nephrologist :: Nuffield Department of Medicine

University of Oxford Apr 01 2002 - May 31 2006

United Kingdom

Clinical Lecturer :: Nuffield Department of Medicine

University of Oxford Apr 01 1999 - Mar 31 2002

United Kingdom

Wellcome Trust Clinical Training Fellow :: Nuffield Department of Medicine

Churchill Hospital Apr 01 1997 - Mar 31 1999

United Kingdom

Specialist Registrar - rotation :: Oxford Kidney Unit

Royal Berkshire Hospital Apr 01 1995 - Mar 31 1997

United Kingdom

Specialist Registrar - rotation :: Medicine

Keele University School of Postgraduate Medicine Aug 01 1992 - Feb 28 1995

United Kingdom

Senior House Officer - Medical rotation :: Medicine

Southampton General Hospital Feb 01 1992 - Jul 31 1992

United Kingdom

House Officer - medicine :: Medicine

St Mary's Hospital, Portsmouth Aug 01 1991 - Jan 31 1992

United Kingdom

House Officer - surgery :: General Surgery / Urology

Publications

Samvid Kurlekar, Joana Darc Carola Correia Lima, Ran Li, Olivia Lombardi, Norma Masson, Ayslan B Barros, Virginia Pontecorvi, David R Mole, Christopher W Pugh, Peter J Ratcliffe, Peter J Ratcliffe
Oncogenic Cell Tagging and Single-Cell Transcriptomics Reveal Cell Type-Specific and Time-Resolved Responses to Vhl Inactivation in the Kidney. Cancer research 84 (11) (2024)
Samvid Kurlekar, Joana Darc Carola Correia Lima, Ran Li, Olivia Lombardi, Norma Masson, Ayslan B Barros, Virginia Pontecorvi, David R Mole, Christopher W Pugh, Peter J Ratcliffe, Peter J Ratcliffe
Oncogenic Cell Tagging and Single-Cell Transcriptomics Reveal Cell Type-Specific and Time-Resolved Responses to Vhl Inactivation in the Kidney. Cancer research 84 (11) (2024)
Samvid Kurlekar, Joana Darc Carola Correia Lima, Ran Li, Olivia Lombardi, Norma Masson, Ayslan B Barros, Virginia Pontecorvi, David R Mole, Christopher W Pugh, Peter J Ratcliffe, Peter J Ratcliffe
Oncogenic Cell Tagging and Single-Cell Transcriptomics Reveal Cell Type-Specific and Time-Resolved Responses to Vhl Inactivation in the Kidney. Cancer research 84 (11) (2024)
Samvid Kurlekar, Joana Darc Carola Correia Lima, Ran Li, Olivia Lombardi, Norma Masson, Ayslan B Barros, Virginia Pontecorvi, David R Mole, Christopher W Pugh, Peter J Ratcliffe, Peter J Ratcliffe
Oncogenic cell tagging and single-cell transcriptomics reveal cell type-specific and time-resolved responses to Vhl inactivation in the kidney. Cancer research (2024)
Véronique N Lafleur, Silvia Halim, Hani Choudhry, Peter J Ratcliffe, David R Mole
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma. Life science alliance 6 (4) (2023)
Véronique N Lafleur, Silvia Halim, Hani Choudhry, Peter J Ratcliffe, David R Mole
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma. Life science alliance 6 (4) (2023)
Véronique N Lafleur, Silvia Halim, Hani Choudhry, Peter J Ratcliffe, David R Mole
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma. Life science alliance 6 (4) (2023)
Véronique N Lafleur, Silvia Halim, Hani Choudhry, Peter J Ratcliffe, David R Mole
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma. Life science alliance 6 (4) (2023)
Véronique N Lafleur, Silvia Halim, Hani Choudhry, Peter J Ratcliffe, David R Mole
Multi-level interaction between HIF and AHR transcriptional pathways in kidney carcinoma. Life science alliance 6 (4) (2023)
Karin Purshouse, Sarah Chamberlain, Maria Soares, Mark Tuthill, Andrew Protheroe, David R Mole
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma. BMC cancer 19 (1) (2019)
Virginia Schmid, Veronique N Lafleur, Olivia Lombardi, Ran Li, Rafik Salama, Leandro Colli, Hani Choudhry, Stephen Chanock, Peter J Ratcliffe, David R Mole
Co-incidence of RCC-susceptibility polymorphisms with HIF cis-acting sequences supports a pathway tuning model of cancer. Scientific reports 9 (1) (2019)
James A Smythies, Min Sun, Norma Masson, Rafik Salama, Peter D Simpson, Elizabeth Murray, Viviana Neumann, Matthew E Cockman, Hani Choudhry, Peter J Ratcliffe, David R Mole
Inherent DNA-binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin. EMBO reports 20 (1) (2018)
James L Platt, Rafik Salama, James Smythies, Hani Choudhry, James Oj Davies, Jim R Hughes, Peter J Ratcliffe, David R Mole
Capture-C reveals preformed chromatin interactions between HIF-binding sites and distant promoters. EMBO reports 17 (10) (2016)

David R Mole.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David R Mole